Irofulven in Treating Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of irofulven in treating patients who have
metastatic breast cancer. Drugs used in chemotherapy use different ways to stop tumor cells
from dividing so they stop growing or die.